MODTX Stock Overview
Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Modus Therapeutics Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr1.03 |
| 52 Week High | kr3.60 |
| 52 Week Low | kr0.88 |
| Beta | 0.31 |
| 1 Month Change | -17.67% |
| 3 Month Change | -50.24% |
| 1 Year Change | -60.27% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -80.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| MODTX | SE Biotechs | SE Market | |
|---|---|---|---|
| 7D | 2.0% | -0.8% | -1.6% |
| 1Y | -60.3% | -5.1% | 7.8% |
Return vs Industry: MODTX underperformed the Swedish Biotechs industry which returned -5.1% over the past year.
Return vs Market: MODTX underperformed the Swedish Market which returned 7.8% over the past year.
Price Volatility
| MODTX volatility | |
|---|---|
| MODTX Average Weekly Movement | 8.3% |
| Biotechs Industry Average Movement | 9.3% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 12.8% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: MODTX's share price has been volatile over the past 3 months.
Volatility Over Time: MODTX's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 2 | John Öhd | www.modustx.com |
Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. Its lead product is Sevuparin, a lipopolysaccharide to treat patients with sepsis, septic shock, and other systemic inflammation conditions, which is under Phase Ib clinical study. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
Modus Therapeutics Holding AB (publ) Fundamentals Summary
| MODTX fundamental statistics | |
|---|---|
| Market cap | kr36.84m |
| Earnings (TTM) | -kr17.90m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.1x
P/E RatioIs MODTX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MODTX income statement (TTM) | |
|---|---|
| Revenue | kr0 |
| Cost of Revenue | kr0 |
| Gross Profit | kr0 |
| Other Expenses | kr17.90m |
| Earnings | -kr17.90m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | -0.50 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did MODTX perform over the long term?
See historical performance and comparison